Feb 17, 2026 07:46AM
Feb 17, 2026 07:45AM
Feb 2, 2026 07:45AM
Feb 2, 2026 07:45AM
Dec 11, 2025 07:30AM
Dec 11, 2025 07:30AM
Nov 14, 2025 07:00AM TuHURA Biosciences, Inc. Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
Aug 14, 2025 04:15PM
Jun 30, 2025 06:52AM
Jun 24, 2025 08:04AM
Jun 24, 2025 08:00AM
Jun 23, 2025 09:16AM
Jun 9, 2025 10:12AM
Jun 9, 2025 08:01AM TuHURA Biosciences (HURA) Says FDA Removed Partial Clinical Hold on Phase 3 Accelerated Approval Trial for IFx-2.0
Jun 9, 2025 08:00AM
Jun 3, 2025 10:00AM
Jun 3, 2025 09:58AM
Jun 2, 2025 08:03AM
May 15, 2025 04:10PM
May 13, 2025 08:00AM
May 5, 2025 08:06AM TuHURA Biosciences (HURA) Initiates Phase 1b/2a Study of IFx-Hu2.0 as an Adjunctive Therapy to Keytruda in First Line Treatment for MCCUP
May 5, 2025 08:00AM
Apr 1, 2025 08:00AM
Mar 11, 2025 08:05AM
Nov 25, 2024 08:39AM
Nov 25, 2024 08:35AM
Oct 17, 2024 04:38PM
Oct 17, 2024 04:35PM TuHURA Biosciences Completes Merger Transaction with Kintara Therapeutics

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All